Comparative Pharmacology
Head-to-head clinical analysis: ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE versus GAVISCON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE versus GAVISCON.
ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE vs GAVISCON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aluminum hydroxide and magnesium trisilicate act as antacids by neutralizing gastric hydrochloric acid, increasing gastric pH, and inhibiting pepsin activity. Aluminum hydroxide forms aluminum phosphate in the intestine. Magnesium trisilicate reacts with HCl to form magnesium chloride and silicic acid, which may provide additional protective coating.
Gaviscon forms a protective alginate raft on top of gastric contents, providing a physical barrier that prevents reflux of gastric acid into the esophagus. The alginate reacts with gastric acid to form a gel-like foam that floats on the stomach contents. Gaviscon also contains antacids (calcium carbonate and sodium bicarbonate) that neutralize gastric acid.
10-20 mL (of suspension containing 200 mg aluminum hydroxide and 200 mg magnesium trisilicate per 5 mL) orally 1 hour after meals and at bedtime, up to 4 times daily.
10-20 mL orally after meals and at bedtime, maximum 80 mL/day
None Documented
None Documented
Aluminum: terminal half-life in patients with normal renal function is approximately 8 hours for absorbed fraction, but may extend to days in renal failure. Magnesium: half-life of absorbed magnesium is 4-6 hours. Clinical context: accumulation risk in chronic kidney disease.
Not applicable; Gaviscon acts locally in the stomach without systemic absorption of active ingredients. The alginate raft persists for 2-4 hours post-dose.
Aluminum and magnesium ions are minimally absorbed. Absorbed aluminum is primarily excreted renally (elimination half-life prolonged in renal impairment); unabsorbed components are eliminated in feces. Magnesium trisilicate may dissociate; absorbed magnesium is excreted renally. Fecal elimination accounts for >95% of the dose.
Primarily fecal as insoluble alginate rafts; minimal renal elimination (<1%) as absorbed components (sodium, potassium, calcium) excreted in urine.
Category C
Category C
Antacid
Antacid